Details werden geladen...
New pancreatic cancer pill could reshape treatment as early trial results stun researchers
A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 patients with RAS mutations.
Ähnliche Seiten
New treatment offers hope for endometrial cancer patients
https://nypost.com/2026/05/20/health/new-treatment-offers-hope-for-endometrial-cancer-patients/
Immunotherapy could be used to treat depression, early trial suggests | Depression | The Guardian
https://www.theguardian.com/society/2026/may/20/immunotherapy-drug-tocilizumab-potential-treatment-depression-uk-trial
How a Revolutionary Cancer Treatment Could Reset the Immune Systems of Patients With Autoimmune Diseases
https://www.smithsonianmag.com/innovation/how-a-revolutionary-cancer-treatment-could-reset-the-immune-systems-of-patients-with-autoimmune-diseases-180988753/
Hidden sugar patterns on human cells could reveal cancer early | ScienceDaily
https://www.sciencedaily.com/releases/2026/05/260517211431.htm
Inside a CU Anschutz clinical trial for a new oral GLP-1 weight loss drug | CU Connections
https://connections.cu.edu/stories/inside-cu-anschutz-clinical-trial-new-oral-glp-1-weight-loss-drug